Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Gaboxadol – Investigational Agent

Drug (brand/generic)

Gaboxadol

Company/licensee

Lundbeck / Merck & Co

Therapy class

GABAA agonist

Product description

Direct-acting GABAA agonist that interacts directly with the GABA receptor site

Current indication

Treatment of insomnia

Market sector

CNS

Development status

Phase III
Expand
Close
Close
Close

Go Top